Dose-dependent effects of Cerebrolysin® on EEG and short term memory of healthy volunteers during control and hyperventilation induced cerebral ischemia

Journal of Neural Transmission, Supplement

Volumn , Issue 53, 1998, Pages 385-398

  Funke, M ^a   Fiehler, J ^a   Mewes, I ^a   Eiselt, M ^a   Rother, I ^a   Windisch, M ^b  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b Ebewe   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CEREBROLYSIN; AMINO ACID; NOOTROPIC AGENT;

ADULT; ARTICLE; BRAIN ISCHEMIA; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; ELECTROENCEPHALOGRAM; HUMAN; HUMAN EXPERIMENT; HYPERVENTILATION; NORMAL HUMAN; PRIORITY JOURNAL; SHORT TERM MEMORY; COGNITION; DOUBLE BLIND PROCEDURE; ELECTROENCEPHALOGRAPHY; MALE; PSYCHOLOGICAL ASPECT; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL;

ADULT; AMINO ACIDS; BRAIN ISCHEMIA; COGNITION; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; HUMANS; HYPERVENTILATION; MALE; MEMORY, SHORT-TERM; NOOTROPIC AGENTS; PSYCHOMOTOR PERFORMANCE;

EID: 0031596289     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6467-9_34     Document Type: Article

References (28)

1. Baschek I-L, Bredenkamp J, Oehrle B, Wippich W (1977) Bestimmung der Bildhaftigkeit (I), Konkretheit (C) und der Bedeutungshaltigkeit (m') von 800 Substantiven. Z Exp Angew Psychol 3: 353-396
2. Baskys A, Wojtowicz MJ (1994) Effects of brain tissue hydrolysate on synaptic transmission in the hippocampus. Pharmacol Biochem Behav 49/4: 1105-1197
3. Bednarczyk EM, Rutherford WF, Leisure GP, Munger MA, Panacek EA, Miraldi FD, Green JA (1990) Hyperventilation-induced reduction in cerebral blood flow: assessment by positron emission tomography. DICP, Ann Pharmacother 24: 456-460
4. Francis-Turner L, Valouskova V, Morky J (1996) Long-term effect of NGF, b-FGF and Cerebrolysin on the spatial memory after fimbria-fornix lesion in rats. J Neural Transm 47: 277
5. Hermann WM, Fichte K, Itil TM, Kubicki St. (1978) Acute efficacy of 20 Psychotropic drugs on human EEG power spectrum variables shown by multivariate and univariate statistics. In: Saletu B, Berner P, Hollister L (eds) Neuropsychopharmacology. Pergamon Press, New York, pp 371-382
6. Hutter-Paier B, Eggenreich U, Windisch M (1996) Effects of twwo protein-free peptide derivates on passive avoidance behaviour of 24-month-old rats. Arzneimittelforschung/Drug Res 46/1: 237-241
7. Iakhno NN, Damulin IV, Zakharov VV, Levin OS, Elkin MN (1996) Experience with using high doses of cerebrolysin in vascular dementia (in russian). Terapevticheskii Arkhiv 68: 65-69
8. Kessler J, Markowitsch HJ, Bast-Kessler C (1987) Memory of alcoholic patients, including Korsakoff s, tested with a Brown-Peterson paradigm. Arch Psychol 139: 115-132
9. Kraaier V, van Huffelen AC, Wieneke GH (1989) The hyperventilation-induced ischaemia model in human neuropharmacology: neurophysiological and psychometric studies of aniracetam and 3-OH aniracetam. Eur J Clin Pharmacol 36: 605-611
10. Kraaier V, Van Huffelen AC, Wieneke GH, Keppel Hesselink JM (1991) Nimodipine tested in human model of cerebral ischaemia. Electroencephalographic and transcranial Doppler ultrasound investigations in normal subjects during standardized hyperventilation. Eur J Clin Pharmacol 40: 17-21
11. Kugler J, Groll S, Upmeyer H-J, Schmidt A (1996) Nicergolin in der Behandlung organischer Psychosyndrome im Alter -ein Beitrag zur Aufklärung der pharmakodynamischen Effekte. Z Gerontopsychol Psychiatr 4: 277-284
12. Paier B, Windisch M, Eggenreich U (1992) Postnatal administration of two peptide solutions affects passive avoidance behaviour of young rats. Behav Brain Res 51: 23-28
13. Rosadini G, Sannita WG, Nobili F, Cenacchi T (1990/91) Phosphatidylserine: quantitative EEG effects in healthy volunteers. Neuropsychobiology 24: 42-48
14. Rüther E, Ritter R, Apecechea M, Freytag S, Windisch M (1994) Efficacy of peptidergic nootropic drug Cerebrolysin in patients with senile dementia of Alzheimer type (SDAT). Pharmacopsychiatry 27: 32-40
15. Saletu B, Anderer P, Kinsperger K, Grünberger J (1988) EEG-Imaging in Psychopharmakologie und Pharmakopsychiatrie. Neuropsychiatrie 2: 269-284
16. Saletu B, Grünberger J, Anderer P, Linzmayer L, Semlitsch HV, Magni G (1992) Pharmacodynamics of venlafaxine evaluated by EEG brain mapping, psychometry and psychophysiology. Br J Clin Pharmacol 33: 589-601
17. Saletu B, Grünberger J, Anderer P, Linzmayer L, Konig P (1995) Acute central effects of the calcium channel blocker and antiglutamatergic drug caroverine. Double-blind, placebo-controlled, EEG mapping and psychometric studies after intravenous and oral administration. Arzneimittelforschung 45: 217-229
18. Saletu B, Grünberger J, Linzmayer L, Anderer P (1996) Brain protection of nicergoline against hypoxia: EEG brain mapping and psychometry. J Neural Transm 2: 305-325
19. Saletu B, Grünberger J, Anderer P, Linzmayer L, Konig P (1996) On the cerebroprotective effects of caroverine, a calcium-channel blocker and antiglutamergic drug: double-blind, placebo-controlled, EEG mapping and psychometric studies under hypoxia. Br J Clin Pharmacol 41: 89-99
20. Saletu B, Grünberger J, Anderer P, Linzmayer L (1996) Effects of the novel neuroprotective agent, riluzole, on human brain function and behavior. I. Double-blind, placebo-controlled EEG mapping and psychometric studies under normoxia. Methods Find Exp Clin Pharmacol 18: 55-66
21. Saletu B, Hitzenberger G, Grünberger J, Anderer P, Zyhlarz G, Linzmayer L, Rameis H (1995) Double-blind placebo-controlled, pharmacokinetic and -dynamic studies with 2 new formulations of piracetam (infusion and sirup) under hypoxia in man. Intern J Clin Pharmacol Ther 33: 249-262
22. Satout T, Itoh T, Fujimoto M, Hashimoto S (1994) Neurotrophic-loke effects of FPF-1070 on cultured neurons from chik embryonic dorsal root ganglia. Jpn Pharmacol Ther 22/4: 205-212
23. Vereschagin NV, Nekrasova YM, Lebedova NV, Suslina ZA, Soloviev OI, Priadov MA, Altunina M (1991) Mild forms of multi-infarct dementia: efficacy of Cerebrolysin. Sov Med 11: 1-6
24. Wenzel JM, Grosse G, Lindner G, Kirsche W, Matthies H (1977) Die Wirkung von Aminosäuren auf die vitro-Differenzierung von Hippocampusneuronen - morphometrische und elektronenmikroskopische Untersuchungen über Ribosomen, Proteinsynthese und Synaptogenese. J Hirnforschung 18: 357-371
25. Windisch M, Piswanger A (1985) Beeinflussung des oxidativen Stoffwechsels von Hirn-, Leber- und Herzmuskelhomogenaten durch Peptidderivate und Kälberblutdialysat in vitro. Arzneimittelforschung/Drug Res 35: 87-89
26. Windisch M, Paier B, Eggenreich U (1994) Neuronal growth factors and their role in degenerative brain diseases: a mini-review. Neurol Croat 43/2: 9-20
27. Xiong H, Baskys A, Wojtowicz JM (1996) Brain-derived peptides inhibit synaptic transmission via presynaptic GABA-B receptors in CA1 area of rat hippocampal slices. Brain Res 737: 188-194
28. Xiong H, Wojtowicz JM, Baskys A (1995) Brain tissue hydrolysate acts on presynaptic adenosine receptors in the rat hippocampus. Can J Physiol Pharmacol 73: 1194-1197